Raheela Ashfaq

14.1k citations
194 papers · 10.1k · 1 hit paper · h-index 58

Impact in

  • Oncology top 0.5%
    • Pancreatic and Hepatic Oncology Research
    • HER2/EGFR in Cancer Research
    • Cancer Genomics and Diagnostics

Papers in

    • Pancreatic and Hepatic Oncology Research 26
    • Cancer-related Molecular Pathways 13
    • Bladder and Urothelial Cancer Treatments 35
    • Urinary and Genital Oncology Studies 21

Raheela Ashfaq

193 papers receiving 9.8k citations

Raheela Ashfaq's Hit Papers

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial 2017 · 406 citations
4060+3+6Years since publication100200300400

Peers

Raheela Ashfaq
Comparison fields: 5 of 147
  • Oncology 3.8k
  • Cancer Research 1.9k
  • Reproductive Medicine 647
  • Surgery 3.0k
  • Molecular Biology 4.0k
Replace Michiie Sakamoto with:
Michiie Sakamoto Japan
David J. Dabbs United States
Gustavo Baretton Germany
Jonathan A. Fletcher United States
Arndt Hartmann Germany
Ronald Simon Germany
Hikmat Al‐Ahmadie United States
William F. Benedict United States
Nam Hoon Cho South Korea
Jahn M. Nesland Norway
Raheela Ashfaq relative to Michiie Sakamoto Japan Michiie Sakamoto's profile →
Citations per field
00.5×1.7×
Michiie Sakamoto · 1×
Citations per year

Countries citing papers authored by Raheela Ashfaq

Since Specialization
Citations

This map shows the geographic impact of Raheela Ashfaq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raheela Ashfaq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raheela Ashfaq more than expected).

Fields of papers citing papers by Raheela Ashfaq

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raheela Ashfaq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raheela Ashfaq. The network helps show where Raheela Ashfaq may publish in the future.

Co-authors

The 25 scholars most cited alongside Raheela Ashfaq, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raheela Ashfaq Line = papers co-authored together Raheela Ashfaq links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
Hit paper breakdown →
2017406
2 2003394
3
Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
2003344
4 1998242
5 2002241
6
5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
2001218
7 1997214
8 2004198
9 2003175
10 2007157
11 2004153
12 2000150
13 2007148
14 2004140
15 2002135
16 2006134
17 2006130
18 2004127
19 2006127
20
Comparison of features of human breast cancer cell lines and their corresponding tumors.
1998124

About Raheela Ashfaq

Raheela Ashfaq is a scholar working on Oncology, Surgery, Molecular Biology, Pathology and Forensic Medicine and Epidemiology, having authored 194 papers that have together received 10.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (35 papers), Pancreatic and Hepatic Oncology Research (26 papers), Cervical Cancer and HPV Research (23 papers), Urinary and Genital Oncology Studies (21 papers), Genetic factors in colorectal cancer (15 papers), Cancer-related Molecular Pathways (13 papers), Epigenetics and DNA Methylation (12 papers) and Cancer Research and Treatments (12 papers). The work is most often cited by research in Oncology (3.8k citations), Cancer Research (1.9k citations), Reproductive Medicine (647 citations), Surgery (3.0k citations) and Molecular Biology (4.0k citations). Raheela Ashfaq has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Yair Lotan, Shahrokh F. Shariat, Anirban Maitra, Arthur I. Sagalowsky, M. Hossein Saboorian, Christine A. Iacobuzio–Donahue, Charles J. Yeo, Ralph H. Hruban, Pierre I. Karakiewicz and John L. Cameron. Their work appears in journals such as Cancer, The Journal of Urology, American Journal of Clinical Pathology, Diagnostic Cytopathology and American Journal Of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact